0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)

M. R. Mirza; R. Depont; B. Lund; J. Lindegaard; N. Keldsen; A. Mellemgaard; K. Bertelsen

doi:10.1136/ijgc-00009577-200610001-00073

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

ABSTRACT: Oral Poster Presentations: Cervical Cancer Tuesday, October 17, 2006

0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)

	Abstract	Full	Pdf
Apr 2022	0	0	2
Total	0	0	2

Main menu

Online download statistics by month:

Online download statistics by month: April 2022 to April 2022

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: April 2022 to April 2022

Read the full text or download the PDF:

Log in using your username and password